Granules India (NSE:GRANULES) Net Margin %

: 10.87% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Granules India's Net Income for the three months ended in Dec. 2023 was ₹1,257 Mil. Granules India's Revenue for the three months ended in Dec. 2023 was ₹11,556 Mil. Therefore, Granules India's net margin for the quarter that ended in Dec. 2023 was 10.87%.

The historical rank and industry rank for Granules India's Net Margin % or its related term are showing as below:

NSE:GRANULES' s Net Margin % Range Over the Past 10 Years
Min: 6.87 Med: 10.83 Max: 17.19
Current: 8.76

NSE:GRANULES's Net Margin % is ranked better than
65.03% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.75 vs NSE:GRANULES: 8.76

Granules India Net Margin % Historical Data

The historical data trend for Granules India's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Granules India Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Net Margin %

10.58

13.18

17.19

11.07

11.49

Granules India Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %																10.85	10.14	4.86	8.58	10.87

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Granules India's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Granules India Net Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Granules India's Net Margin % distribution charts can be found below:

* The bar in red indicates where Granules India's Net Margin % falls into.

Granules India Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Granules India's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin	=	Net Income (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	5165.97	/	44963.38
	=	11.49 %

Granules India's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	1256.52	/	11555.84
	=	10.87 %

Granules India (NSE:GRANULES) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Granules India Net Margin % Related Terms

Thank you for viewing the detailed overview of Granules India's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Granules India (NSE:GRANULES) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Granules India Ltd (NSE:GRANULES) » Definitions » Net Margin %

Traded in Other Exchanges

532482:India

Address

3rd Block, My Home Hub, 2nd Floor, Madhapur, Hyderabad, TG, IND, 500 081

Website

https://www.granulesindia.com

Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.

Granules India (NSE:GRANULES) Headlines

No Headlines